Clario (Thermo Fisher)
Category: Medical imaging — Full-service
Service Model: Full-service + Technology
Geography: Global
HQ: United States
Leading endpoint data capture platform combining eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints. Acquired by Thermo Fisher for $8.9B. Supported 19,000+ trials and 870+ regulatory approvals.
Best for: Complex multi-endpoint trials,Cardiac safety,Medical imaging,eCOA + imaging combined
Strengths: Only platform combining eCOA, cardiac safety, imaging, motion, respiratory, 19,000+ trials supported, 870+ regulatory approvals, Thermo Fisher ecosystem integration
https://www.clario.com
View full profile on Clinical Vendor Compare
